Purified Argonaute2 and an siRNA form recombinant human RISC

FV Rivas, NH Tolia, JJ Song, JP Aragon, J Liu… - Nature structural & …, 2005 - nature.com
FV Rivas, NH Tolia, JJ Song, JP Aragon, J Liu, GJ Hannon, L Joshua-Tor
Nature structural & molecular biology, 2005nature.com
Genetic, biochemical and structural studies have implicated Argonaute proteins as the
catalytic core of the RNAi effector complex, RISC. Here we show that recombinant, human
Argonaute2 can combine with a small interfering RNA (siRNA) to form minimal RISC that
accurately cleaves substrate RNAs. Recombinant RISC shows many of the properties of
RISC purified from human or Drosophila melanogaster cells but also has surprising features.
It shows no stimulation by ATP, suggesting that factors promoting product release are …
Abstract
Genetic, biochemical and structural studies have implicated Argonaute proteins as the catalytic core of the RNAi effector complex, RISC. Here we show that recombinant, human Argonaute2 can combine with a small interfering RNA (siRNA) to form minimal RISC that accurately cleaves substrate RNAs. Recombinant RISC shows many of the properties of RISC purified from human or Drosophila melanogaster cells but also has surprising features. It shows no stimulation by ATP, suggesting that factors promoting product release are missing from the recombinant enzyme. The active site is made up of a unique Asp-Asp-His (DDH) motif. In the RISC reconstitution system, the siRNA 5′ phosphate is important for the stability and the fidelity of the complex but is not essential for the creation of an active enzyme. These studies demonstrate that Argonaute proteins catalyze mRNA cleavage within RISC and provide a source of recombinant enzyme for detailed biochemical studies of the RNAi effector complex.
nature.com